A Threat to Abortion Pills. Plus, the U.S. Sh...

As the general midterm elections begin, we take a look at where things stand. A new Times/Siena poll suggests that Democrats have a real shot at winning control of both chambers of Congress. But serious obstacles stand in their way, including a financial disadvantage.The New York ...  Afficher plus

For the past few months, you’ve probably been hearing about the turbulence in the bond market.Today, Ben Casselman, the chief economics correspondent for The New York Times, explains what has been happening, and why it matters.Guest: Ben Casselman, the chief economics corresponde ...  Afficher plus

A federal judge in Texas invalidated the FDA’s decades-old approval of the abortion drug mifepristone. Vox’s Anna North explains the battle over a drug that’s been legal since 2000. This episode was produced by Avishay Artsy and Hady Mawajdeh, edited by Matthew Collette, fact-che ...  Afficher plus

Today on Post Reports, we take you to an abortion hearing in Amarillo, Tex., that the judge didn’t want you to know was coming. 

Read more:

In a four-hour hearing on Wednesday, U.S. District Judge Matthew Kacsmaryk heard arguments in

If you thought the overturning of Roe v Wade- the constitutional right to an abortion in the United States was the end of it in 2022, then 2023 has other ideas. Or rather the radical, anti-abortion groups in the United States have other ideas. Just this week, Florida’s Governor ( ...  Afficher plus

A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications. Read the story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices